Skip to main content
. 2024 Mar 4;14:5365. doi: 10.1038/s41598-024-55320-1

Figure 2.

Figure 2

Solicited systemic and local adverse events (AEs) 7 days after each dose. The systemic (A) and local (B) AEs are reported by dose, treatment and maximum severity. Participants were monitored for solicited systemic and local AEs from the time of vaccination through 7 days after each dose. Occurrence of the events from Grade 1 to Grade 3 are represented as percentage of participants. No Grade 4 (potentially life-threatening) events were reported by participants.